Get Adverse syndromes and psychiatric drugs: a clinical guide PDF

By Peter M. Haddad, Serdar Dursun, Bill Deakin

ISBN-10: 0198527489

ISBN-13: 9780198527480

Show description

Read or Download Adverse syndromes and psychiatric drugs: a clinical guide PDF

Best clinical books

New PDF release: Brain Protection: Morphological, Pathophysiological and

Major growth has potentially been made within the box of cere­ bral safety in comparison to previous centuries, as lately reviewed by means of Elisabeth Frost (6). She cites the strategies for deal with­ ment of mind trauma through Areteus, a Greek healthcare professional of the second one century A. D. He expressed relatively modem perspectives with reference to the necessity for urged motion contemplating issues that keep on with even minor signs.

Download e-book for kindle: Clinical Evaluation of Medical Devices: Principles and Case by Karen M. Becker PhD (auth.), Karen M. Becker PhD, John J.

Hugely praised in its first version, scientific evaluate of scientific units: rules and Case experiences, moment variation has been multiplied and up to date to incorporate the numerous strategies and scientific study tools that experience constructed because the first version, in addition to present details at the regulatory, criminal, and compensation atmosphere for clinical units.

Additional info for Adverse syndromes and psychiatric drugs: a clinical guide

Example text

Risk factors for neuroleptic malignant syndrome; a case control study. Arch Gen Psychiatry, 46, 914–18. Keck PE, Pope HG, and McElroy SL (1991). Declining frequency of neuroleptic malignant syndrome in a hospital population. Am J Psychiatry, 148, 880–2. Kellam AMP (1990). The (frequently) neuroleptic (potentially) malignant syndrome. Br J Psychiatry, 157, 169–73. Kohen D and Bristow M (1996). Neuroleptic malignant syndrome. Adv Psychiatr Treat, 2, 151–7. Kohen D and Bristow M (1999). Atypical antipsychotics and neuroleptic malignant syndrome.

Although there are well documented cases of NMS occurring in elderly patients, over 80 per cent of cases are under 40 years of age (Caroff 1980), a finding that has been attributed to the use of higher doses of psychotropics in younger age groups. Recently, increased awareness of NMS, better understanding of psychopharmacological issues, decreased use of antipsychotic polypharmacy and of high doses of antipsychotic drugs have all assisted in decreasing the incidence of NMS (Gelenberg et al. 1988; Keck et al.

1992). Tardive Dyskinesia: A Task Force Report of the American Psychiatric Association. The American Psychiatric Association: Washington, DC. Kane JM (1999). Tardive dyskinesia. ), pp. 31–5. Blackwell Science: Malden, MA. Kapur S, Zipursky R, Jones C, et al. (2000). Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. Am J Psychiatry, 157, 514–20. Kennedy PF, Hershon HI, and McGuire RJ (1971). Extrapyramidal disorders after prolonged phenothiazine therapy, including a factor analytic study of clinical features.

Download PDF sample

Adverse syndromes and psychiatric drugs: a clinical guide by Peter M. Haddad, Serdar Dursun, Bill Deakin

by Robert

Rated 4.06 of 5 – based on 35 votes